Pregabalin Open Access Articles | Open Access Journals

International Journal of Neurorehabilitation

ISSN: 2376-0281

Open Access

Pregabalin Open Access Articles

 Pregabalin, showcased under the brand name Lyrica among others, is a drug used to treat epilepsy, neuropathic torment, fibromyalgia, anxious leg condition, and summed up tension issue. Its utilization in epilepsy is as an extra treatment for halfway seizures. At the point when utilized before medical procedure, it diminishes torment however brings about more prominent sedation and visual aggravations. It is taken by mouth. Common reactions incorporate cerebral pain, dazedness, drowsiness, disarray, issue with memory, helpless coordination, dry mouth, issue with vision, and weight gain. Genuine reactions may incorporate angioedema, medicate abuse, and an expanded self destruction risk.  When pregabalin is taken at high dosages over a significant stretch of time, compulsion may happen, yet whenever taken at regular portions the hazard is low. Use during pregnancy or breastfeeding is of indistinct security. Pregabalin is a gabapentinoid and acts by repressing certain calcium channels.It was affirmed for clinical use in the United States in 2004. It was created as a replacement to gabapentin. It is accessible as a nonexclusive medicine in various nations, including the United States starting at 2019.

Relevant Topics in Neuroscience & Psychology

Google Scholar citation report
Citations: 1078

International Journal of Neurorehabilitation received 1078 citations as per Google Scholar report

International Journal of Neurorehabilitation peer review process verified at publons

Indexed In

arrow_upward arrow_upward